192 related articles for article (PubMed ID: 30266942)
1. Systems biology approach reveals a link between mTORC1 and G2/M DNA damage checkpoint recovery.
Hsieh HJ; Zhang W; Lin SH; Yang WH; Wang JZ; Shen J; Zhang Y; Lu Y; Wang H; Yu J; Mills GB; Peng G
Nat Commun; 2018 Sep; 9(1):3982. PubMed ID: 30266942
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.
Zhan J; Chitta RK; Harwood FC; Grosveld GC
Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133
[TBL] [Abstract][Full Text] [Related]
4. RIPK1 Promotes Energy Sensing by the mTORC1 Pathway.
Najafov A; Luu HS; Mookhtiar AK; Mifflin L; Xia HG; Amin PP; Ordureau A; Wang H; Yuan J
Mol Cell; 2021 Jan; 81(2):370-385.e7. PubMed ID: 33271062
[TBL] [Abstract][Full Text] [Related]
5. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
6. Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.
Posey KL; Coustry F; Veerisetty AC; Hossain MG; Gambello MJ; Hecht JT
Am J Pathol; 2019 Jan; 189(1):132-146. PubMed ID: 30553437
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells.
Zhou X; Liu W; Hu X; Dorrance A; Garzon R; Houghton PJ; Shen C
Sci Rep; 2017 May; 7(1):1535. PubMed ID: 28484242
[TBL] [Abstract][Full Text] [Related]
8. S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair.
Amar-Schwartz A; Ben Hur V; Jbara A; Cohen Y; Barnabas GD; Arbib E; Siegfried Z; Mashahreh B; Hassouna F; Shilo A; Abu-Odeh M; Berger M; Wiener R; Aqeilan R; Geiger T; Karni R
Elife; 2022 Oct; 11():. PubMed ID: 36189922
[TBL] [Abstract][Full Text] [Related]
9. TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
Ogórek B; Lam HC; Khabibullin D; Liu HJ; Nijmeh J; Triboulet R; Kwiatkowski DJ; Gregory RI; Henske EP
Hum Mol Genet; 2018 May; 27(9):1654-1663. PubMed ID: 29509898
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
Abroudi A; Samarasinghe S; Kulasiri D
J Theor Biol; 2017 Sep; 429():204-228. PubMed ID: 28647496
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.
Wang J; Filippakis H; Hougard T; Du H; Ye C; Liu HJ; Zhang L; Hindi K; Bagwe S; Nijmeh J; Asara JM; Shi W; El-Chemaly S; Henske EP; Lam HC
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544857
[TBL] [Abstract][Full Text] [Related]
12. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells.
Sakai Y; Kassai H; Nakayama H; Fukaya M; Maeda T; Nakao K; Hashimoto K; Sakagami H; Kano M; Aiba A
Sci Rep; 2019 Feb; 9(1):2799. PubMed ID: 30808980
[TBL] [Abstract][Full Text] [Related]
13. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
[TBL] [Abstract][Full Text] [Related]
14. Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways.
Pal R; Xiong Y; Sardiello M
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2977-2986. PubMed ID: 30728291
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.
Mrozek EM; Bajaj V; Guo Y; Malinowska IA; Zhang J; Kwiatkowski DJ
PLoS One; 2021; 16(4):e0248380. PubMed ID: 33891611
[TBL] [Abstract][Full Text] [Related]
16. MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
Oeing CU; Jun S; Mishra S; Dunkerly-Eyring BL; Chen A; Grajeda MI; Tahir UA; Gerszten RE; Paolocci N; Ranek MJ; Kass DA
Circ Res; 2021 Mar; 128(5):639-651. PubMed ID: 33401933
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways.
Zolotovskaia MA; Modestov AA; Suntsova MV; Rachkova AA; Koroleva EV; Poddubskaya EV; Sekacheva MI; Tkachev VS; Garazha AV; Glusker AA; Seryakov AP; Vladimirova US; Rumiantsev PO; Moisseev AA; Zharkov DO; Kuzmin DV; Zhao X; Prassolov VS; Shegay PV; Li X; Steinbichler TB; Kim E; Sorokin MI; Wang Y; Buzdin AA
DNA Repair (Amst); 2023 Mar; 123():103448. PubMed ID: 36657260
[TBL] [Abstract][Full Text] [Related]
18. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma.
Barnaba N; LaRocque JR
Cell Cycle; 2021 Jun; 20(11):1041-1051. PubMed ID: 33966611
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci.
Kelsey I; Zbinden M; Byles V; Torrence M; Manning BD
Sci Rep; 2017 Nov; 7(1):16112. PubMed ID: 29170467
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells.
Beirowski B; Wong KM; Babetto E; Milbrandt J
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4261-E4270. PubMed ID: 28484008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
